Consultation on the third legislative review of the Tobacco and Vaping Products Act

Current status: Closed

This consultation ran from June 27, 2025 to September 12, 2025.
This review, the third legislative review of the Tobacco and Vaping Products Act (TVPA), focused on compliance and enforcement issues identified in the final reports for the first and the second reviews.

The final report will be tabled in Parliament and will be made public on Canada.ca.

The objective of the consultation

A key part of the legislative review consultation was to seek the perspectives of Canadians, experts, and other stakeholders as they relate to compliance and enforcement of the TVPA.

Those who were invited to provide feedback included:

Related information

Canada introduced new measures to regulate tobacco and vaping products and a new tobacco control strategy in 2018. The Tobacco Act of 1997 was amended and renamed the Tobacco and Vaping Products Act (TVPA) and Canada's Tobacco Strategy (CTS) was launched to address tobacco use in Canada. CTS sets an ambitious target to reduce the prevalence of tobacco use to less than 5 percent by 2035. Health Canada has set interim targets of reducing tobacco use among those 18 years and older to 11 percent by 2025 and 9 percent by 2030. It also has set a target of reducing vaping use among those aged 12 to 17 to below 10 percent by 2025.

To achieve this target, CTS aims to prioritize helping Canadians quit tobacco, protect youth and people who do not use tobacco from nicotine addiction. Additionally, it aims to support First Nations, Inuit and Métis organizations to develop and implement their own self-determined, culturally appropriate and distinct approaches to reducing commercial tobacco use based on their own needs and priorities, and strengthen science, surveillance, and partnerships.

The TVPA includes a requirement to undertake a legislative review of its provisions and operation three years after coming-into-force, and every two years thereafter. The public consultation will help support the evidence-based analysis and review of the legislation.

Contact us

Manager, Legislative Review
Office of Policy and Strategic Planning
Tobacco Control Directorate
Controlled Substances and Cannabis Branch, Health Canada
5004A – 405 Terminal Avenue
Ottawa, Ontario, K1G 0Z3
Email: legislativereviewtvpa.revisionlegislativeltpv@hc-sc.gc.ca

Page details

2025-10-16